Atalanta have outperformed their expectations in the Champions League this season and will now make one final push in their ...
Barcelona take on Atalanta in their final league phase match in the Champions League, knowing that a victory would ensure a ...
Sitting second in the UEFA Champions League table, Barcelona hope to secure not only a Round of 16 bye but a top-four ...
Barcelona defender Alejandro Balde may have unwittingly handed his side's Champions League opponents Atalanta some extra ...
Serie A side Atalanta take on Barcelona in the Champions League tomorrow and the game will determine where both sides finish ...
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.
Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.
As FC Barcelona get set to take on Atalanta BC in the UEFA Champions League on Wednesday night at Estadi Olimpic Lluis ...